Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
STK24 antisense RNA 1 (STK24-AS1)
- Target
- STK24-AS1
- Molecular classification
- Other (long non-coding RNA, lncRNA)
01
Overview
STK24 antisense RNA 1 (STK24-AS1) is a long non-coding RNA (lncRNA) classified by its antisense orientation to the STK24 gene. It does not code for a protein and is believed to exert regulatory roles at the transcriptional or post-transcriptional level[4]. STK24-AS1 has been implicated in gene expression regulation, with studies suggesting that its expression profile may serve as a specific biomarker distinguishing ischemic stroke (IS) patients from matched controls[5]. Its function appears to be related to regulatory networks involving other lncRNAs, transcription factors, and coding genes, with possible links to the PI3K/Akt signaling pathway in disease processes[5]. There is currently no evidence that STK24-AS1 itself is a therapeutic target, drug receptor, or directly druggable enzyme or protein.
- Other names
- STK24-AS1
02
Biological functions
Regulation of gene expression
03
Disease associations
Ischemic stroke (potential biomarker)Other (as lncRNA, possible regulatory role in disease)
04
Biomarkers
Potential biomarker for group classification in ischemic stroke (IS) patients and controls[5]
Beyond the preview
Go deeper on STK24 antisense RNA 1 (STK24-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on STK24 antisense RNA 1 (STK24-AS1).